Parallel Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
OHA
Parallel Advisors's EBS Position: Q2 2026 in Review
Parallel Advisors opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 21 shares worth $176. The stake represents ﹤0.01% of the portfolio and ranks #3857 among its holdings. This is a return to the name: Parallel Advisors previously reported a position in EBS as recently as Q4 2023.
Parallel Advisors first reported a position in EBS in Q3 2018 and has held it in 21 quarters since. The position peaked at $15K in Q3 2018. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.
- Parallel Advisors held 21 shares of Emergent Biosolutions worth $176 as of Q2 2026.
- Emergent Biosolutions was a new Parallel Advisors position in Q2 2026.
- Emergent Biosolutions made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3857 holding.
- Parallel Advisors first reported a position in Emergent Biosolutions in Q3 2018 and has held it in 21 quarters since.
- Parallel Advisors's Emergent Biosolutions position peaked at $15K in Q3 2018.
- 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.